Shell Companies
Build Your Comparison
Side-by-side financial analysisStock Comparison
CGCT vs EVR vs JPM
Revenue, margins, valuation, and 5-year total return — side by side.
Financial - Capital Markets
Banks - Diversified
CGCT vs EVR vs JPM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||
|---|---|---|---|
| Industry | Shell Companies | Financial - Capital Markets | Banks - Diversified |
| Market Cap | $424M | $14.15B | $896.00B |
| Revenue (TTM) | $0.00 | $3.88B | $280.33B |
| Net Income (TTM) | $6M | $592M | $57.05B |
| Gross Margin | — | 99.4% | 60.0% |
| Operating Margin | — | 20.5% | 25.9% |
| Forward P/E | 61.4x | 18.6x | 14.4x |
| Total Debt | $0.00 | $1.16B | $942.38B |
| Cash & Equiv. | $624K | $1.47B | $343.34B |
CGCT vs EVR vs JPM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 25 | Jun 26 | Return |
|---|---|---|---|
| Cartesian Growth Co… (CGCT) | 100 | 153.1 | +53.1% |
| Evercore Inc. (EVR) | 100 | 154.4 | +54.4% |
| JPMorgan Chase & Co. (JPM) | 100 | 121.5 | +21.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CGCT vs EVR vs JPM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CGCT is the clearest fit if your priority is sleep-well-at-night and bank quality.
- Lower volatility, beta 0.25, current ratio 0.89x
- NIM 2.6% vs JPM's 2.2%
- Beta 0.25 vs EVR's 1.83
EVR is the clearest fit if your priority is growth exposure and long-term compounding.
- Rev growth 29.5%, EPS growth 54.7%
- 6.7% 10Y total return vs JPM's 465.8%
- 29.5% NII/revenue growth vs JPM's 3.3%
JPM carries the broadest edge in this set and is the clearest fit for income & stability and valuation efficiency.
- Dividend streak 15 yrs, beta 0.94, yield 1.9%
- PEG 0.81 vs EVR's 1.64
- Beta 0.94, yield 1.9%, current ratio 0.52x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 29.5% NII/revenue growth vs JPM's 3.3% | |
| Value | Lower P/E (14.4x vs 18.6x), PEG 0.81 vs 1.64 | |
| Quality / Margins | Efficiency ratio 0.3% vs EVR's 0.8% (lower = leaner) | |
| Stability / Safety | Beta 0.25 vs EVR's 1.83 | |
| Dividends | 1.9% yield, 15-year raise streak, vs EVR's 0.9%, (1 stock pays no dividend) | |
| Momentum (1Y) | +52.2% vs JPM's +21.8% | |
| Efficiency (ROA) | Efficiency ratio 0.3% vs EVR's 0.8% |
CGCT vs EVR vs JPM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
CGCT vs EVR vs JPM — Financial Metrics
Side-by-side numbers across 3 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
JPM leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
JPM and CGCT operate at a comparable scale, with $280.3B and $0 in trailing revenue. JPM is the more profitable business, keeping 20.4% of every revenue dollar as net income compared to EVR's 15.3%.
| Metric | |||
|---|---|---|---|
| RevenueTrailing 12 months | $0 | $3.9B | $280.3B |
| EBITDAEarnings before interest/tax | — | $804M | $81.4B |
| Net IncomeAfter-tax profit | — | $592M | $57.0B |
| Free Cash FlowCash after capex | — | $1.2B | $100.9B |
| Gross MarginGross profit ÷ Revenue | — | +99.4% | +60.0% |
| Operating MarginEBIT ÷ Revenue | — | +20.5% | +25.9% |
| Net MarginNet income ÷ Revenue | — | +15.3% | +20.4% |
| FCF MarginFCF ÷ Revenue | — | +30.5% | +36.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | — | +44.2% | +16.0% |
Valuation Metrics
JPM leads this category, winning 5 of 7 comparable metrics.
Valuation Metrics
At 16.0x trailing earnings, JPM trades at a 74% valuation discount to CGCT's 61.4x P/E. Adjusting for growth (PEG ratio), JPM offers better value at 0.90x vs EVR's 2.25x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||
|---|---|---|---|
| Market CapShares × price | $424M | $14.2B | $896.0B |
| Enterprise ValueMkt cap + debt − cash | $423M | $13.8B | $1.50T |
| Trailing P/EPrice ÷ TTM EPS | 61.44x | 25.44x | 16.00x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 18.60x | 14.40x |
| PEG RatioP/E ÷ EPS growth rate | — | 2.25x | 0.90x |
| EV / EBITDAEnterprise value multiple | — | 17.21x | 18.36x |
| Price / SalesMarket cap ÷ Revenue | — | 3.65x | 3.20x |
| Price / BookPrice ÷ Book value/share | 1.03x | 6.84x | 2.47x |
| Price / FCFMarket cap ÷ FCF | — | 11.97x | 8.88x |
Profitability & Efficiency
EVR leads this category, winning 8 of 9 comparable metrics.
Profitability & Efficiency
EVR delivers a 29.3% return on equity — every $100 of shareholder capital generates $29 in annual profit, vs $5 for CGCT. EVR carries lower financial leverage with a 0.50x debt-to-equity ratio, signaling a more conservative balance sheet compared to JPM's 2.60x. On the Piotroski fundamental quality scale (0–9), EVR scores 6/9 vs CGCT's 3/9, reflecting solid financial health.
| Metric | |||
|---|---|---|---|
| ROE (TTM)Return on equity | +4.6% | +29.3% | +15.9% |
| ROA (TTM)Return on assets | +4.4% | +14.1% | +1.3% |
| ROICReturn on invested capital | -0.6% | +18.8% | +4.5% |
| ROCEReturn on capital employed | -0.8% | +17.6% | +8.9% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 6 | 5 |
| Debt / EquityFinancial leverage | — | 0.50x | 2.60x |
| Net DebtTotal debt minus cash | -$624,163 | -$311M | $599.0B |
| Cash & Equiv.Liquid assets | $624,163 | $1.5B | $343.3B |
| Total DebtShort + long-term debt | $0 | $1.2B | $942.4B |
| Interest CoverageEBIT ÷ Interest expense | — | 32.72x | 0.74x |
Total Returns (Dividends Reinvested)
EVR leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in EVR five years ago would be worth $27,319 today (with dividends reinvested), compared to $15,314 for CGCT. Over the past 12 months, CGCT leads with a +52.2% total return vs JPM's +21.8%. The 3-year compound annual growth rate (CAGR) favors EVR at 44.8% vs CGCT's 15.3% — a key indicator of consistent wealth creation.
| Metric | |||
|---|---|---|---|
| YTD ReturnYear-to-date | +48.8% | +2.2% | -0.5% |
| 1-Year ReturnPast 12 months | +52.2% | +46.0% | +21.8% |
| 3-Year ReturnCumulative with dividends | +53.1% | +203.4% | +138.2% |
| 5-Year ReturnCumulative with dividends | +53.1% | +173.2% | +118.2% |
| 10-Year ReturnCumulative with dividends | +53.1% | +672.5% | +465.8% |
| CAGR (3Y)Annualised 3-year return | +15.3% | +44.8% | +33.6% |
Risk & Volatility
Evenly matched — CGCT and JPM each lead in 1 of 2 comparable metrics.
Risk & Volatility
CGCT is the less volatile stock with a 0.25 beta — it tends to amplify market swings less than EVR's 1.83 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. JPM currently trades 95.1% from its 52-week high vs CGCT's 89.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||
|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.25x | 1.83x | 0.94x |
| 52-Week HighHighest price in past year | $17.25 | $388.71 | $337.25 |
| 52-Week LowLowest price in past year | $9.27 | $238.96 | $262.71 |
| % of 52W HighCurrent price vs 52-week peak | +89.0% | +91.9% | +95.1% |
| RSI (14)Momentum oscillator 0–100 | 57.7 | 57.3 | 59.1 |
| Avg Volume (50D)Average daily shares traded | 187K | 457K | 7.0M |
Analyst Outlook
Evenly matched — EVR and JPM each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: EVR as "Buy", JPM as "Buy". Consensus price targets imply 7.1% upside for EVR (target: $383) vs 5.9% for JPM (target: $340). For income investors, JPM offers the higher dividend yield at 1.86% vs EVR's 0.91%.
| Metric | |||
|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy |
| Price TargetConsensus 12-month target | — | $382.67 | $339.75 |
| # AnalystsCovering analysts | — | 21 | 61 |
| Dividend YieldAnnual dividend ÷ price | — | +0.9% | +1.9% |
| Dividend StreakConsecutive years of raises | — | 19 | 15 |
| Dividend / ShareAnnual DPS | — | $3.25 | $5.95 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +4.7% | +3.9% |
JPM leads in 2 of 6 categories (Income & Cash Flow, Valuation Metrics). EVR leads in 2 (Profitability & Efficiency, Total Returns). 2 tied.
CGCT vs EVR vs JPM: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CGCT or EVR or JPM a better buy right now?
For growth investors, Evercore Inc.
(EVR) is the stronger pick with 29. 5% revenue growth year-over-year, versus 3. 3% for JPMorgan Chase & Co. (JPM). JPMorgan Chase & Co. (JPM) offers the better valuation at 16. 0x trailing P/E (14. 4x forward), making it the more compelling value choice. Analysts rate Evercore Inc. (EVR) a "Buy" — based on 21 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CGCT or EVR or JPM?
On trailing P/E, JPMorgan Chase & Co.
(JPM) is the cheapest at 16. 0x versus Cartesian Growth Corporation III at 61. 4x. On forward P/E, JPMorgan Chase & Co. is actually cheaper at 14. 4x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: JPMorgan Chase & Co. wins at 0. 81x versus Evercore Inc. 's 1. 64x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — CGCT or EVR or JPM?
Over the past 5 years, Evercore Inc.
(EVR) delivered a total return of +173. 2%, compared to +53. 1% for Cartesian Growth Corporation III (CGCT). Over 10 years, the gap is even starker: EVR returned +672. 5% versus CGCT's +53. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CGCT or EVR or JPM?
By beta (market sensitivity over 5 years), Cartesian Growth Corporation III (CGCT) is the lower-risk stock at 0.
25β versus Evercore Inc. 's 1. 83β — meaning EVR is approximately 635% more volatile than CGCT relative to the S&P 500. On balance sheet safety, Evercore Inc. (EVR) carries a lower debt/equity ratio of 50% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.
05Which is growing faster — CGCT or EVR or JPM?
By revenue growth (latest reported year), Evercore Inc.
(EVR) is pulling ahead at 29. 5% versus 3. 3% for JPMorgan Chase & Co. (JPM). On earnings-per-share growth, the picture is similar: Cartesian Growth Corporation III grew EPS 589. 2% year-over-year, compared to 1. 5% for JPMorgan Chase & Co.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CGCT or EVR or JPM?
JPMorgan Chase & Co.
(JPM) is the more profitable company, earning 20. 4% net margin versus 0. 0% for Cartesian Growth Corporation III — meaning it keeps 20. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: JPM leads at 26. 0% versus 0. 0% for CGCT. At the gross margin level — before operating expenses — EVR leads at 99. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CGCT or EVR or JPM more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, JPMorgan Chase & Co. (JPM) is the more undervalued stock at a PEG of 0. 81x versus Evercore Inc. 's 1. 64x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, JPMorgan Chase & Co. (JPM) trades at 14. 4x forward P/E versus 18. 6x for Evercore Inc. — 4. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for EVR: 7. 1% to $382. 67.
08Which pays a better dividend — CGCT or EVR or JPM?
In this comparison, JPM (1.
9% yield), EVR (0. 9% yield) pay a dividend. CGCT does not pay a meaningful dividend and should not be held primarily for income.
09Is CGCT or EVR or JPM better for a retirement portfolio?
For long-horizon retirement investors, JPMorgan Chase & Co.
(JPM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 94), 1. 9% yield, +465. 8% 10Y return). Evercore Inc. (EVR) carries a higher beta of 1. 83 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (JPM: +465. 8%, EVR: +672. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CGCT and EVR and JPM?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: CGCT is a small-cap quality compounder stock; EVR is a mid-cap high-growth stock; JPM is a large-cap deep-value stock. EVR, JPM pay a dividend while CGCT does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.